• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?在肝切除术后的肝细胞癌患者中，肌少症性肥胖作为预测指标是否优于肌少症？
Hepatobiliary Surg Nutr. 2020 Apr;9(2):202-204. doi: 10.21037/hbsn.2019.09.14.
2
Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.体成分对肝癌患者肝切除术后生存和发病率的影响。
Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):28-37. doi: 10.1016/j.hbpd.2018.07.008. Epub 2018 Jul 26.
3
Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.肌少症性肥胖对肝细胞癌患者肝切除术后结局的影响。
Ann Surg. 2019 May;269(5):924-931. doi: 10.1097/SLA.0000000000002555.
4
Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?肌肉减少症、肥胖症和肌肉减少性肥胖症能否预测结直肠癌肝转移患者的预后？
HPB (Oxford). 2015 May;17(5):438-46. doi: 10.1111/hpb.12373. Epub 2014 Dec 16.
5
Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.肌少性肥胖：食管癌患者新辅助化疗期间剂量限制性毒性的一个潜在危险因素。
Clin Nutr. 2016 Jun;35(3):724-30. doi: 10.1016/j.clnu.2015.05.011. Epub 2015 May 27.
6
Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.在接受肝移植评估的肝硬化患者中，非酒精性脂肪性肝炎与肌少症肥胖密切相关。
J Gastroenterol Hepatol. 2016 Mar;31(3):628-33. doi: 10.1111/jgh.13166.
7
Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?肌少症和肌少症肥胖与接受根治性肾输尿管切除术患者的临床和病理结果相关吗？
Urol Oncol. 2018 Apr;36(4):156.e17-156.e22. doi: 10.1016/j.urolonc.2017.12.004. Epub 2017 Dec 21.
8
Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection.肌肉减少症、肥胖症和肌少症性肥胖：对计划进行大型肝切除术患者肝功能和肝脏体积的影响。
J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):155-63. doi: 10.1002/jcsm.12018. Epub 2015 Apr 28.
9
Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma.肌肉减少症会损害潜在可治愈的肝细胞癌患者的生存率。
J Surg Oncol. 2015 Aug;112(2):208-13. doi: 10.1002/jso.23976. Epub 2015 Aug 12.
10
Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity.与年龄相关的身体成分变化（肌肉减少症、肥胖症和肌少性肥胖症）相关的健康相关生活质量和跌倒风险。
Intern Med J. 2018 Aug;48(8):973-981. doi: 10.1111/imj.13935.

引用本文的文献

1
Progress in the application of fludeoxyglucose positron emission tomography computed tomography in biliary tract cancer.氟脱氧葡萄糖正电子发射断层扫描计算机断层扫描在胆道癌中的应用进展
World J Hepatol. 2025 May 27;17(5):105446. doi: 10.4254/wjh.v17.i5.105446.
2
Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status.肥胖是肝内胆管癌进展的一个风险因素，与代谢活性和免疫状态的改变有关。
Sci Rep. 2021 Mar 12;11(1):5845. doi: 10.1038/s41598-021-85186-6.

本文引用的文献

1
Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection.炎症生物标志物在肝癌肝切除术后的预后意义。
BJS Open. 2019 Apr 29;3(4):500-508. doi: 10.1002/bjs5.50170. eCollection 2019 Aug.
2
Sarcopenic Obesity: Time to Meet the Challenge.肌少症性肥胖：是时候迎接挑战了。
Obes Facts. 2018;11(4):294-305. doi: 10.1159/000490361. Epub 2018 Jul 18.
3
Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.肌少症性肥胖对肝细胞癌患者肝切除术后结局的影响。
Ann Surg. 2019 May;269(5):924-931. doi: 10.1097/SLA.0000000000002555.
4
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.2015 年全球疾病负担研究：1990 年至 2015 年全球、区域和国家一级原发性肝癌及相关病因负担。
JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055.
5
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria.日本肝脏学会肝病相关肌少症指南（第 1 版）：肌少症评估标准制定工作组的推荐意见。
Hepatol Res. 2016 Sep;46(10):951-63. doi: 10.1111/hepr.12774.
6
Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study.身体质量指数和胆固醇水平可预测台湾肝细胞癌患者的手术结果——一项队列研究。
Oncotarget. 2016 Apr 19;7(16):22948-59. doi: 10.18632/oncotarget.8312.
7
Prognostic Impact of Visceral Fat Amount and Branched-Chain Amino Acids (BCAA) in Hepatocellular Carcinoma.内脏脂肪量和支链氨基酸（BCAA）对肝细胞癌的预后影响
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1041-7. doi: 10.1245/s10434-015-4796-5. Epub 2015 Aug 25.
8
Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy.肥胖不影响肝细胞癌患者根治性肝切除术后的预后。
PLoS One. 2015 May 12;10(5):e0125649. doi: 10.1371/journal.pone.0125649. eCollection 2015.
9
Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma.身体组成对肝细胞癌肝切除术后结局的影响。
Ann Surg Oncol. 2014 Sep;21(9):3063-8. doi: 10.1245/s10434-014-3686-6. Epub 2014 Apr 10.
10
Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.骨骼肌减少症作为预测肝细胞癌患者肝切除术后预后的指标。
Br J Surg. 2013 Oct;100(11):1523-30. doi: 10.1002/bjs.9258.

Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?

作者信息

Itoh Shinji, Yoshizumi Tomoharu, Mori Masaki

机构信息

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Hepatobiliary Surg Nutr. 2020 Apr;9(2):202-204. doi: 10.21037/hbsn.2019.09.14.

DOI:10.21037/hbsn.2019.09.14
PMID:32355679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7188538/
Abstract
摘要